Related Experiment Video
Updated: Jan 13, 2026
Analysis of Cell Suspensions Isolated from Solid Tissues by Spectral Flow Cytometry
Published on: May 5, 2017
Assessment of feline peripheral blood lymphocyte subpopulations and CD18 expression pattern by flow cytometry
Patricia Lindiman1, Rosina Sánchez Solé1, Paula Pessina1,2
1Laboratorio de Análisis Clínicos, Endocrinología y Metabolismo Animal, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, Universidad de la República, Montevideo, 13000, Uruguay.
Insights
This study quantifies feline lymphocyte subpopulations in healthy cats using flow cytometry. Findings reveal distinct CD18 expression patterns, crucial for diagnosing feline hematopoietic diseases.
Area of Science:
- Veterinary Immunology
- Feline Hematology
- Immunophenotyping
Background:
- Flow cytometry is vital for diagnosing hematopoietic malignancies but limited in feline medicine due to antibody scarcity.
- Current feline studies primarily analyze lymph node lymphocytes, with less focus on bone marrow and peripheral blood.
Purpose of the Study:
- To assess the utility of peripheral blood for feline lymphocyte subpopulation quantification via flow cytometry.
- To establish baseline immunophenotypic data in healthy cats for future disease studies.
Main Methods:
- Peripheral blood samples from 15 healthy cats were analyzed using flow cytometry with specific antibody panels.
- Quantification of lymphocyte subpopulations, including T cells (CD5+, CD4+, CD8+) and B cells (CD21+).
- Analysis of CD18 expression patterns on lymphocytes.
Main Results:
- Total leukocytes (CD18+) comprised a median of 89.7% of peripheral blood cells.
- CD5+ T cells were the predominant lymphocyte subset, followed by CD21+ B cells.
- CD4+ helper T cells outnumbered CD8+ cytotoxic T cells, and a biphasic CD18 expression pattern was observed in lymphocytes.
Conclusions:
- This study provides the first report of a biphasic CD18 expression pattern in feline peripheral blood lymphocytes.
- Established baseline immunophenotypic profiles are essential for advancing feline immunological research and diagnostics.
- These findings support broader flow cytometry application in feline medicine for improved disease diagnosis and monitoring.
Abstract:
Flow cytometry-based immunophenotyping plays a critical role in the diagnosis, classification, staging, and monitoring of hematopoietic malignancies. However, its application in feline medicine remains limited primarily because of the scarcity of species-specific antibodies. Existing studies in cats predominantly focus on analyzing lymphocyte subpopulations in lymph nodes, with fewer investigations conducted on bone marrow and peripheral blood. This study aimed to assess the utility of peripheral blood samples from healthy cats for quantifying lymphocyte subpopulations by flow cytometry to provide basic data useful for future studies on animals with diseases. Using specific antibody panels, we successfully quantified lymphocyte subpopulations in 15 healthy cats. Total leukocytes (CD18+) accounted for a median of 89.7% of peripheral blood cells. Among lymphocytes, CD5+ T cells were the predominant subset, followed by CD21+ B cells. Among T cells, CD4+ helper cells outnumbered CD8+ cytotoxic cells. Notably, CD18 expression exhibited a biphasic pattern: B lymphocytes showed lower fluorescence intensity compared with T lymphocytes. In some cases, three distinct fluorescence peaks suggested further heterogeneity within the T-cell population. To the best of our knowledge, this is the first study to clearly identify a biphasic expression pattern of CD18 in the peripheral blood lymphocytes of cats. These findings reveal the complexity of immune cell marker expression in the peripheral blood of felines and support the broader application of flow cytometry in feline immunological and diagnostic research. The establishment of these baseline immunophenotypic profiles in healthy cats is crucial for improving the diagnosis and monitoring of feline hematopoietic diseases, ultimately contributing to better clinical management and therapeutic strategies.
